Amgen
One of the world's largest independent biotechnology companies developing and manufacturing human therapeutics.
Amgen About PageAmgen Inc. is a global biotechnology company headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, the company focuses on developing therapeutics for oncology, cardiology, inflammation, bone health, and rare diseases.
With a workforce of over 25,000 employees worldwide, Amgen reported total revenues of approximately $33.4 billion in 2024. Its extensive product portfolio includes Enbrel, Prolia, and Otezla, and was expanded through the 2023 acquisition of Horizon Therapeutics, adding products such as Tepezza and Krystexxa.
The company is currently focusing its pipeline on bispecifics, rare disease expansion, and obesity treatments, specifically MariTide.